Drugs acting via vascular disruption and related birth defects: a systematic review

Y. H. Tran; H. Wang; J. E. H. Bergman; H. Groen; M. K. Bakker; B. Wilffert

doi:10.1002/pds.3868

Drugs acting via vascular disruption and related birth defects: a systematic review

Y. H. Tran, H. Wang, J. E. H. Bergman, H. Groen, M. K. Bakker, B. Wilffert

Onderzoeksoutput › Academic

Originele taal-2	English
Artikelnummer	P25
Pagina's (van-tot)	33-33
Aantal pagina's	1
Tijdschrift	Pharmcoepidemiology and Drug Safety
Volume	24
Nummer van het tijdschrift	Suppl. 2:33
DOI's	https://doi.org/10.1002/pds.3868
Status	Published - okt.-2015
Evenement	Cancer and Primary Care Research International (Ca-PRI) Network 8th Annual Meeting, 20 may 2015 - , Denmark Duur: 20-mei-2017 → 20-mei-2017

Toegang tot document

10.1002/pds.3868

Handle.net

Permanente koppeling

Citeer dit

@article{d70c663ea7fa44c484600910b7c0d08d,

title = "Drugs acting via vascular disruption and related birth defects: a systematic review",

author = "Tran, {Y. H.} and H. Wang and Bergman, {J. E. H.} and H. Groen and Bakker, {M. K.} and B. Wilffert",

note = "Drugs acting via vascular disruption and related birth defects: a systematic review.: P25; Cancer and Primary Care Research International (Ca-PRI) Network 8th Annual Meeting, 20 may 2015 ; Conference date: 20-05-2017 Through 20-05-2017",

year = "2015",

month = oct,

doi = "10.1002/pds.3868",

language = "English",

volume = "24",

pages = "33--33",

journal = "Pharmcoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "Wiley",

number = "Suppl. 2:33",

}

TY - JOUR

T1 - Drugs acting via vascular disruption and related birth defects

T2 - Cancer and Primary Care Research International (Ca-PRI) Network 8th Annual Meeting, 20 may 2015

AU - Tran, Y. H.

AU - Wang, H.

AU - Bergman, J. E. H.

AU - Groen, H.

AU - Bakker, M. K.

AU - Wilffert, B.

N1 - Drugs acting via vascular disruption and related birth defects: a systematic review.: P25

PY - 2015/10

Y1 - 2015/10

U2 - 10.1002/pds.3868

DO - 10.1002/pds.3868

M3 - Meeting Abstract

SN - 1053-8569

VL - 24

SP - 33

EP - 33

JO - Pharmcoepidemiology and Drug Safety

JF - Pharmcoepidemiology and Drug Safety

IS - Suppl. 2:33

M1 - P25

Y2 - 20 May 2017 through 20 May 2017

ER -